Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mindfulness may help tame alcohol cravings by reconnecting body and mind

NCT ID NCT07706660

Disease control Sponsor: Medical University of Warsaw Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 16, 2026 · Last updated Aug 25, 2026 · Updated 3 times

Summary

This trial tests whether a six-week body-focused mindfulness program can help people with alcohol use disorder feel more connected to their bodies, manage emotions better, and reduce alcohol cravings. Participants in inpatient treatment will either take part in mindfulness sessions or standard psychoeducation. Researchers will track changes in body awareness, emotional regulation, and drinking behavior for up to a year after leaving the hospital.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a body-focused mindfulness program including breath-focused meditation, body scan, mindful movement, and stretching, delivered in six weekly 90-minute group sessions
What this could lead to
If it works, this could offer a new, drug-free way to help people with alcohol use disorder reduce cravings and stay sober after treatment.
What could go wrong
This is a relatively small, early-stage trial, and the mindfulness program may not prove more effective than standard psychoeducation. Results depend on self-reported measures, which can be unreliable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 240 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2026

Expected to finish

Dec 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of Alcohol Use Disorder (DSM-5) * Currently admitted to the inpatient AUD treatment program at the study ward * Age 18 years or older * Written informed consent provided Exclusion Criteria: * Refusal to participate or withdrawal of consent * Severe somatic condition precluding participation in group activities * Current acute psychotic symptoms * Severe affective symptoms requiring intensive intervention * High current suicide risk * Epileptic seizure within 2 weeks prior to randomization * Intellectual disability or significant cognitive impairment preventing understanding of or adherence to the study protocol * Severe personality disorder with current self-harm or other-harm behaviors

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Alcohol use disorder (AUD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Affective Symptoms alcohol abuse alcohol-related disorders Emotional Regulation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Alcohol use disorder (AUD) Alcohol-related disorders

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ward XVIII for Alcohol Use Disorder Treatment, Nowowiejski Hospital, Warsaw

    RECRUITING

    Warsaw, Mazovian, 01-045, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.